Top Natural Language Processing Companies (510)

Strong Revenue Growth: FY2026 results show company sales increased to roughly $8.0B, with underlying (comparable) growth strengthening after excluding the divested business. Brand-level detail indicates Coach delivered robust double-digit gains that powered the consolidated uptrend.

Profitability: Adjusted operating income and earnings per share rose markedly for FY2026 alongside operating-margin expansion. Management’s FY2027 outlook also calls for further margin improvement with low double-digit EPS growth.

Market Expansion: Growth was broad-based geographically, with notable increases in Europe and Greater China and continued strength in direct-to-consumer channels. The customer base expanded by millions in FY2026, including a meaningful Gen Z cohort.

Product Line Growth: The portfolio has expanded with LLM-ready APIs, additional financial datasets, MCP Apps, and Adaptive Retrieval, broadening the financial research and analysis workflows it can support. Announcements across 2026 indicate continued investment in AI infrastructure and data-access capabilities.

Market Expansion: Customer adoption and usage are rising, with customers under contract or trial increasing from 300+ in Q1 2026 to 500+ in Q2 and API call volumes accelerating markedly. Enterprise-scale deployments, such as the RBC Capital Markets rollout to 8,000 employees, show reach into large institutions.

Future-Ready Strategy: S&P Global’s July 2026 reorganization created a Kensho Data & Platforms vertical that places AI and data delivery at the center of product strategy. This organizational move underscores Kensho’s strategic importance in advancing AI-enabled products and workflows.

Investor Backing & Capital Strength: Investor backing is underscored by a majority investment from Vitruvian Partners in 2026 with plans to expand AI capabilities, enter new markets, grow international presence, and pursue acquisitions. This signals access to growth capital and strategic support.

Strong Revenue Growth: Industry research characterizes the company as one of the fastest-growing in its space in 2025, indicating strong commercial momentum beyond internal announcements. This aligns with broader signals of scale such as an extensive customer base and large annual translation volume.

Innovation-Driven Growth: AI and AI-human translation usage increased markedly in 2025 alongside launches of new AI features like quality evaluation, translation automation, and agentic localization. These developments suggest product-led expansion and growing enterprise adoption.

Strong Revenue Growth: Revenue at the original email business is described as rising from roughly $30M ARR at the end of 2024 to about $35M by mid-2025, based on independent estimates. This points to solid momentum ahead of the acquisition.

Product Line Growth: The company broadened its suite beyond Mail to include Grammarly, Docs, and Go, and added meeting intelligence via the Fathom acquisition. This expansion indicates intentional widening of use cases and monetization paths.

Market Expansion: A new Seattle office with capacity for additional headcount and stated plans to keep hiring reflect continued geographic and workforce build-out. The organization also reports a large global team, underscoring operational scale.

Strong Revenue Growth: Revenue was described as doubling annually into 2025, with separate market analysis estimating roughly $100M in annualized revenue by mid-2026. The company also indicated it entered 2025 cash-flow positive, underscoring momentum in the business.

Investor Backing & Capital Strength: A $130 million Series C at a $1.3 billion valuation drew new strategic investors alongside existing backers, signaling deep capital support for scaling. Independent coverage also notes total funding exceeding $215 million, reinforcing financial flexibility for expansion.

Market Expansion: International reach expanded with plans for Europe and Asia and a Singapore regional hub, alongside reported strong growth in regional API demand. Product scope also widened from transcription into text-to-speech, real-time voice agents, and an industry entry via the OfOne acquisition.

Strong Market Position & Advantage: The company remains a category leader in its niche by share of branded searches and continues to attract very large monthly visit volumes. This points to durable competitive positioning despite mixed growth signals elsewhere.

Product Line Growth: The offering has expanded beyond paraphrasing and grammar into audio, image, search, and other tools. This indicates ongoing investment and a strategy to broaden use cases and monetization paths.

Strategic Partnerships: The business cites roughly 150 education and enterprise partners. This institutional reach supports distribution, credibility, and potential revenue channels.

Product Line Growth: Newer and acquired medicines grew 18% operationally in Q2 2026, while revenue excluding Comirnaty and Paxlovid rose 5% operationally in the same period. Excluding COVID products, 2025 revenue also increased 6% operationally, supported by growth in products such as Eliquis and Padcev.

Cost & Operational Efficiency: Management is pursuing additional savings to improve operational efficiency and support profitability. These cost-control efforts are intended to help the business transition away from pandemic-driven sales while supporting margins.

Innovation-Driven Growth: Investment in future growth includes $10.4 billion in internal R&D during 2025 and ongoing development in oncology and obesity. A broad pipeline and recent acquisitions are intended to offset declining COVID-19 sales and patent expirations if programs succeed.

Strong Revenue Growth: Reported ARR surpassed $200 million in June 2026 with five consecutive years of 100% year-over-year growth, indicating rapid scaling. Adoption breadth, including claims of powering one in six U.S. apartments, reinforces the commercial momentum behind that trajectory.

Investor Backing & Capital Strength: A $350 million round in September 2026 at a $4 billion valuation, with major existing investors participating alongside Ontario Teachers’ Pension Plan, underscores substantial access to capital. This financing signals strong confidence to fund continued product development and go-to-market expansion.

Market Expansion: Reach reportedly grew from about one in twelve U.S. apartments in 2024 to one in six in 2026, alongside plans for a second engineering hub in San Francisco. The company is also expanding from leasing into broader property-management workflows and healthcare administration.

Strong Revenue Growth: ARR is described as rising from roughly $13M in 2024 to nearly $50M by 2026, and recent updates note new ARR tripling quarter over quarter. These signals point to substantial top-line acceleration over the last two years.

Market Expansion: EMEA revenue reportedly grew 373% year over year from FY2025 to FY2026, with plans to triple the regional team and more than double account executives. This combination of sales momentum and hiring suggests widening international reach.

Strong Market Position & Advantage: Major financial institutions are adopting the platform at scale, including a Morgan Stanley deployment covering about 5,000 workers and broad use among top asset managers with many production use cases. High usage levels (e.g., crossing 1 billion pages processed) indicate deeper embedment in enterprise workflows.

Market Expansion: The company opened offices in Arlington, VA (2024) and Seattle, WA (2025), moves described as supporting continued growth, customer access, and recruiting. This expanded footprint indicates deliberate entry into new regions tied to defense customers and talent pools.

Innovation-Driven Growth: Substantial awards spanning AI-enabled systems, autonomous aircraft, and DARPA research (including a $66.7M Army data/software contract, a $98M ceiling AI/T&E vehicle, and a $48.05M Army autonomous-aircraft agreement) point to growth anchored in advanced technologies. Selection as a prime on R&D vehicles further underscores momentum in applied AI and autonomy.

Strong Market Position & Advantage: Prime selections and sizable U.S. Army and DARPA programs, along with rising multi-year federal obligations since FY2022, suggest strengthening competitive standing in defense technology. Access to government-wide vehicles such as IAC MAC Pool 2 expands routes to future task orders.

Strong Revenue Growth: Feedback suggests AKASA reports more than tenfold growth since mid-2024 and nearly sixfold year-over-year inpatient volume processed, indicating rapid commercial traction and usage expansion.

Market Expansion: Feedback suggests deployments have broadened across major U.S. health systems, with a footprint reportedly spanning roughly 500 hospitals and customers representing about 10% of U.S. inpatient discharges.

Investor Backing & Capital Strength: Feedback suggests AKASA has attracted substantial capital, with reported total funding around $200M+, providing resources to scale products and partnerships.

Strong Hiring & Retention: Hiring is active across software engineering, testing and infrastructure, technical project management, and network operations, with the careers page stating the company is growing and recruiting. Internship programs further indicate a continuing talent pipeline and investment in delivery capacity.

Product Line Growth: Offerings now span intelligent call routing, pre-call fraud detection and authentication, voice enhancement, conversation analytics, and programmable communications APIs. This broader portfolio points to ongoing development beyond traditional telephony services.

Strong Market Position & Advantage: Operating scale is described as processing billions of minutes annually and supporting roughly one in ten U.S. support calls, with integrations to major telecommunications carriers. These indicators suggest an established enterprise footprint.

Investor Backing & Capital Strength: New funding of $60 million in 2023 and a $30 million Series B in August 2025, led by Norwest with participation from existing investors, indicates continued capital support. The company stated these funds will fuel AI innovation, integrations, and international expansion.

Innovation-Driven Growth: The launch of a standalone enterprise AI platform in March 2026, Kustomer Architect in May 2026, and additional Conversation Intelligence and AI QA capabilities in October 2026 point to active product development. These additions emphasize AI-powered customer service and broaden the platform’s capabilities.

Market Expansion: Introducing an AI platform that works with existing helpdesks (initially including Zendesk) extends reach beyond customers replacing their core systems. Expansion priorities also include international growth, as outlined alongside the 2025 financing.

Strong Market Position & Advantage: Waystar’s acquisition materials describe Iodine as serving more than 1,000 hospitals and health systems, indicating substantial commercial reach and competitive positioning.

Product Line Growth: Launches like AwarePre-Bill and expansion into utilization management and pre-bill workflows suggest ongoing investment in new offerings and adjacent use cases.

Strategic Partnerships: Integration into Waystar’s platform creates cross-selling opportunities and unites clinical intelligence with financial data for broader commercialization potential.